Schmidt L G, Lammers V, Stöckel M, Müller-Oerlinghausen B
Department of Psychiatry, Free University of Berlin, Germany.
Pharmacopsychiatry. 1988 May;21(3):126-30. doi: 10.1055/s-2007-1014663.
Analysis of the prescribing of psychotropic drugs in the psychiatric hospital of the Free University of Berlin revealed a slight decrease in the mean number of prescriptions to our patients over recent years. As a response to intensified psychopharmacological pretreatment the proportion of patients who had initially been treated drug-free (up to the 10th day after admission) rose steadily every year. The use of neuroleptics increased significantly, mainly due to increased prescriptions of this group of compounds to endogenous depressives. The use of benzodiazepines, however, decreased in all groups of patients. Simultaneous use of neuroleptics was a clear leader in the category of drug combinations. Low-potent neuroleptics (i.e. perazine, clozapine), clomipramine, and the MAO-inhibitor tranylcypromine were preferred increasingly in recent years; reduced prescription rates were found for haloperidol, clomethiazol, and metamizol. These changes may be related to an ongoing process of reevaluating benefits and risks of available treatments. The systematic updating of prescribing patterns is an essential tool for quality control of psychiatric pharmacotherapy.
对柏林自由大学精神病院精神药物处方情况的分析显示,近年来我们患者的平均处方数量略有下降。作为对强化精神药理学预处理的回应,最初接受无药物治疗(入院后第10天之前)的患者比例逐年稳步上升。抗精神病药物的使用显著增加,主要原因是该类化合物对内源性抑郁症患者的处方量增加。然而,苯二氮䓬类药物在所有患者群体中的使用都有所减少。抗精神病药物的联合使用在药物组合类别中明显占主导地位。近年来,低效价抗精神病药物(如奋乃静、氯氮平)、氯米帕明和单胺氧化酶抑制剂反苯环丙胺越来越受到青睐;氟哌啶醇、氯美噻唑和安乃近的处方率则有所下降。这些变化可能与对现有治疗方法的益处和风险进行持续重新评估的过程有关。处方模式的系统更新是精神科药物治疗质量控制的重要工具。